NEW APPROACH METHODOLOGIES (NAMS): ACCELERATING SAFER, SMARTER AND MORE HUMAN-RELEVANT INNOVATION IN DRUG AND CHEMICAL DEVELOPMENT
Tracks
SPEAKER'S ROOM 2: NICOLÁS ACHÚCARRO
| Wednesday, September 30, 2026 |
| 12:15 - 13:00 |
| SPEAKERS' CORNER 2: NICOLÁS ACHÚCARRO |
Overview
Sponsor: BeCytes (IVT), Fraunhofer Spain Research.
Details
New Approach Methodologies (NAMs) are transforming the way drugs, medical products, and chemicals are evaluated by providing more predictive, human-relevant, and sustainable alternatives to traditional testing approaches. By integrating advanced in vitro models, computational tools, artificial intelligence, in silico toxicology, and innovative preclinical strategies, NAMs offer new opportunities to improve safety assessment, reduce development timelines, lower costs, and support regulatory decision-making.
This round table will bring together leading experts from industry and technology providers to explore the current state and future potential of NAMs across the life sciences sector. The discussion will examine how emerging methodologies are being implemented in research and development workflows, the scientific and regulatory challenges that remain, and the collaborative efforts needed to accelerate adoption.
Representatives from CMG MedDev, ProtoQSAR, Labcorp and IVT Becytes will share their perspectives on the role of digital technologies, predictive modeling, advanced biological systems, and regulatory science in shaping the next generation of safety and efficacy assessment.
Speaker
Carmen Martin Gonzalez
CEO / Founder_senior Expert Consultant
CMG MEDDEV
Moderator
Natalia Sánchez Romero
Senior Scientific Advisor
BeCYTES (a BioIVT Company)
.
John Kendrick
Executive Director, NAMs and Emerging Technologies
Labcorp
.
Simon Perera del Rosario
BD Manager
ProtoQSAR SL
.
Josep Samitier Martí
Executive Director and Center Director
Fraunhofer Spain Research
.
AM Conferences & Meetings, S.L. - C/ Espronceda, 27 - 28003 Madrid